By Anne Dachel
July 7, 2016, Edmonton Alberta MetroNews: Alberta study shows HPV vaccine is 'very effective'
By Kevin Maimann
An Alberta study has proven the effectiveness of the HPV vaccination in protecting against cervical cancer, according to doctors.
Dr. Huiming Yang, who co-authored the study that was published this week in the Canadian Medical Association Journal, says it is the first in North America to demonstrate the vaccine’s effectiveness.
“It was what we hoped for, because the clinical trial data years ago basically showed similar results,” Yang said. “And now we basically have proof that this worked with a real population.”
The study tested more than 10,200 women born between 1994 and 1997 who had at least one pap test between 2012 and 2015.
It found the vaccination is “very effective” in reducing cervical cell abnormalities. Women who completed all three doses of the vaccine were 50 per cent less likely to develop hybrid lesions that have a higher potential to become cancerous later in life....
Meanwhile, anti-vaccine sentiment is still alive in Edmonton. The Princess Theatre came under fire from health professionals this week for screening anti-vaccine film Vaxxed directed by Andrew Wakefield, whose 1998 study claiming links between autism and vaccines has been thoroughly discredited.
What the Alberta MetroNews story tries to do (besides slam Andrew Wakefield for "VaxXed") is pretend that the HPV vaccine prevents cancer. Of course they can't really say that, so they allege that being "less likely to develop hybrid lesions" means that a woman won't get cervical cancer later on. This claim is directly challenged by a Duluth Minnesota physician who believes that the possible side effects outweigh the imagined benefits.
July 5, 2016, A doctor's response: Risks, costs of HPV vaccine far outweigh any benefit
By Gary G. Kohls, MD
A commentary in the June 16 News Tribune, written and endorsed by area board-certified pediatricians, oncologists and obstetricians/gynecologists, promoted the universal use of the human papillomavirus (HPV) vaccine for pre-teen and teen-age girls (A Doctor’s View: “Simple vaccine can prevent cancer’s suffering”).
The commentary appeared to be a part of a worldwide, billion-dollar promotion campaign to get the world’s young women, even in poor, Third World nations, more fully vaccinated. The huge amount of money behind the massive effort comes from one of the most profitable, price-gouging pharmaceutical companies in the world, Merck.
In 2006, after only three to five years of clinical trials, the FDA approved for marketing the most expensive vaccine in the history of the world, Gardasil, which has been proclaimed as preventative for cancer of the cervix, a claim that was never proved and which has, to date, not prevented a single case of cervical cancer.
The premise that the vaccine could prevent cancer was presented by Merck investigators to the FDA, then to American physicians, and now to their patients. The premise was based on findings made by investigators deeply conflicted by their financial involvement with Merck in that they were employees, had shares in the company or had received honoraria or grants to get the product to market and promote the vaccine any way they could.
Scandalously, the truth of the matter is that neither company’s vaccine has ever prevented a single cancer of the cervix, mainly because cancer of the cervix takes 20 to 50 years to develop, and the vaccine corporations only clinically tested the product prior to FDA approval for less than five years....
Gary G. Kohls is a retired medical doctor in Duluth.
Anne Dachel is Media Editor for Age of Autism.